147 related articles for article (PubMed ID: 37697694)
1. Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
Frei AL; McGuigan A; Sinha RR; Glaire MA; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson TJ; Saunders M; Oein K; Maka N; Pezella F; Campo L; Hay J; Edwards J; Sansom OJ; Kelly C; Tomlinson I; Kildal W; Kerr RS; Kerr DJ; Danielsen HE; Domingo E; ; Church DN; Koelzer VH
J Pathol Clin Res; 2023 Nov; 9(6):449-463. PubMed ID: 37697694
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.
Taube JM; Roman K; Engle EL; Wang C; Ballesteros-Merino C; Jensen SM; McGuire J; Jiang M; Coltharp C; Remeniuk B; Wistuba I; Locke D; Parra ER; Fox BA; Rimm DL; Hoyt C
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266881
[TBL] [Abstract][Full Text] [Related]
4. Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.
Ma Z; Shiao SL; Yoshida EJ; Swartwood S; Huang F; Doche ME; Chung AP; Knudsen BS; Gertych A
Diagn Pathol; 2017 Sep; 12(1):69. PubMed ID: 28923066
[TBL] [Abstract][Full Text] [Related]
5. Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
Xie Y; Olkhov-Mitsel E; Alminawi S; Slodkowska E; Downes MR
Pathol Res Pract; 2021 Oct; 226():153607. PubMed ID: 34509050
[TBL] [Abstract][Full Text] [Related]
6. Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images.
Fassler DJ; Abousamra S; Gupta R; Chen C; Zhao M; Paredes D; Batool SA; Knudsen BS; Escobar-Hoyos L; Shroyer KR; Samaras D; Kurc T; Saltz J
Diagn Pathol; 2020 Jul; 15(1):100. PubMed ID: 32723384
[TBL] [Abstract][Full Text] [Related]
7. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
8. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
[TBL] [Abstract][Full Text] [Related]
9. Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma.
Yaseen Z; Gide TN; Conway JW; Potter AJ; Quek C; Hong AM; Long GV; Scolyer RA; Wilmott JS
Front Mol Biosci; 2022; 9():810858. PubMed ID: 35664673
[TBL] [Abstract][Full Text] [Related]
10. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
11. Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system.
Laurinaviciene A; Plancoulaine B; Baltrusaityte I; Meskauskas R; Besusparis J; Lesciute-Krilaviciene D; Raudeliunas D; Iqbal Y; Herlin P; Laurinavicius A
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S10. PubMed ID: 25565007
[TBL] [Abstract][Full Text] [Related]
12. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
[TBL] [Abstract][Full Text] [Related]
13. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
Akturk G; Sweeney R; Remark R; Merad M; Gnjatic S
Methods Mol Biol; 2020; 2055():497-519. PubMed ID: 31502167
[TBL] [Abstract][Full Text] [Related]
14. Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry.
Wu J; Mao L; Sun W; Yang X; Wang H; Liu X; Chi K; Huang X; Lin D
J Clin Pathol; 2022 Jul; 75(7):452-458. PubMed ID: 33782193
[TBL] [Abstract][Full Text] [Related]
15. Observer performance in the use of digital and optical microscopy for the interpretation of tissue-based biomarkers.
Gavrielides MA; Conway C; O'Flaherty N; Gallas BD; Hewitt SM
Anal Cell Pathol (Amst); 2014; 2014():157308. PubMed ID: 25763314
[TBL] [Abstract][Full Text] [Related]
16. ATMAD: robust image analysis for Automatic Tissue MicroArray De-arraying.
Nguyen HN; Paveau V; Cauchois C; Kervrann C
BMC Bioinformatics; 2018 Apr; 19(1):148. PubMed ID: 29673310
[TBL] [Abstract][Full Text] [Related]
17. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
[TBL] [Abstract][Full Text] [Related]
18. High-throughput analysis of tissue-based biomarkers in digital pathology.
Van Eycke YR; Debeir O; Verset L; Demetter P; Salmon I; Decaestecker C
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7732-5. PubMed ID: 26738084
[TBL] [Abstract][Full Text] [Related]
19. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
Peck AR; Girondo MA; Liu C; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Mitchell EP; Freydin B; Hyslop T; Chervoneva I; Rui H
Mod Pathol; 2016 Oct; 29(10):1143-54. PubMed ID: 27312066
[TBL] [Abstract][Full Text] [Related]
20. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
Zlobec I; Koelzer VH; Dawson H; Perren A; Lugli A
J Transl Med; 2013 Apr; 11():104. PubMed ID: 23627766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]